Monday, November 19, 2012

• 1 Biotech That Is Bouncing Backat Motley Fool (Mon, Nov 19)

Friday, November 16, 2012

• Onyx Pharmaceuticals Inc. Stock Hold Recommendation Reiterated (ONXX)at TheStreet (Fri, Nov 16)
• [video] The Next Big Thing In Biotech: Best CEO Candidatesat TheStreet (Fri, Nov 16)

Wednesday, November 14, 2012

• Vertex Pharmaceuticals Among Healthcare's Biggest Movers on November 14, 2012at Investopedia (Wed, Nov 14)
• Facebook Inc. - Class Among the Nasdaq's Biggest Movers on November 14, 2012at Investopedia (Wed, Nov 14)
• Onyx Pharmaceuticals Management Presents at Lazard Capital Markets Healthcare Conference (Transcript)at Seeking Alpha (Wed, Nov 14)
• Onyx Pharmaceuticals' Management Presents at Credit Suisse 2012 Healthcare Conference (Transcript)at Seeking Alpha (Wed, Nov 14)
• It's Time To Buy Back Celgene On Abraxaneat Seeking Alpha (Wed, Nov 14)

Tuesday, November 13, 2012

• EU Nod for Novartis' VotubiaZacks (Tue, Nov 13)
• 3 Biopharma Catalyst Trades To Considerat Seeking Alpha (Tue, Nov 13)

Sunday, November 11, 2012

• Survey Of The Pancreatic Cancer Drug Market With Celgene's Abraxane In Focusat Seeking Alpha (Sun, Nov 11)

Tuesday, November 6, 2012

• Onyx Pharmaceuticals to Present at Upcoming Investor ConferencesMarketwired (Tue, Nov 6)
• Onyx Beats ExpectationsZacks (Tue, Nov 6)
• This Hedge Fund's Picks Have Returned 20% Two Straight Quartersat Motley Fool (Tue, Nov 6)
• Onyx Pharmaceuticals Inc. Stock Hold Recommendation Reiterated (ONXX)at TheStreet (Tue, Nov 6)
• Onyx Pharmaceuticals Announces Data Presentations Highlighting Carfilzomib and Oprozomib at 54th American Society of Hematology Annual MeetingMarketwired (Tue, Nov 6)

Monday, November 5, 2012

• Today's Big Biotech Loserat Motley Fool (Mon, Nov 5)
• Why Did This Drugmaker's Earnings Displease Investors?at Motley Fool (Mon, Nov 5)
• Ligand Pharma should benefit significantly from Onyx drug, says Roth Capitalat theflyonthewall.com (Mon, Nov 5)

Friday, November 2, 2012

• ONYX PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly ReportEDGAR Online (Fri, Nov 2)
• Patients' tales add weight to BayBio awardsat bizjournals.com (Fri, Nov 2)
• Onyx Pharmaceuticals Management Discusses Q3 2012 Results - Earnings Call Transcriptat Seeking Alpha (Fri, Nov 2)
• Vanguard Health Care Fund Does More Shedding than Adding in Third Quarterat Forbes (Fri, Nov 2)

Thursday, November 1, 2012

• Onyx: Initial Kyprolis Sales Blow Past Estimatesat TheStreet (Thu, Nov 1)
• / CORRECTION - Onyx Pharmaceuticals Reports Third Quarter 2012 Financial ResultsMarketwired (Thu, Nov 1)

Add ONXX News to My Yahoo!